1.
Azariani W, Ananto AD, Maulidya SAI. In Silico Assessment of GSK-3? Inhibition Activity by Secondary Metabolites of Centella asiatica in the Development of Alzheimer’s Therapy. J. Trop. Pharm. Chem. [Internet]. 2025 Dec. 31 [cited 2026 May 2];9(2):64-70. Available from: https://jtpc.jurnalfamul.com/index.php/jtpc/article/view/671